Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The CORE Study (Chemotherapy OR Endocrine Treatment First?) A Randomized Study by the Scandinavian Breast Group [CORE]

NCT00403182 is registered in ClinicalTrials.gov with Technical University of Munich as lead sponsor.

NCT NCT00403182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00403182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The CORE Study (Chemotherapy OR Endocrine Treatment First?) A Randomized Study by the Scandinavian Breast Group [CORE]
Lead sponsor
Technical University of Munich
Phase
Phase 3
Overall status
Withdrawn
Start date
May 31, 2006
Completion date
Not reported
Enrollment
0 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer